Evidence map›Paper›PMID 28034999›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2017

Perceptions of Snus Among US Adult Smokers Given Free Product.

Ellen Meier, Jessica L Burris, Amy Wahlquist, Elizabeth Garrett-Mayer, Kevin M Gray, Anthony J Alberg, K Michael Cummings, Matthew J Carpenter

Open access · bronzeAbstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Effects of a Reduced Risk Claim on Adolescents' Smokeless Tobacco Perceptions and Willingness to Use.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2023
    Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ellen MeierDepartment of Psychiatry, University of Minnesota, Minneapolis, MN.
Jessica L BurrisDepartment of Psychology, University of Kentucky, Lexington, KY.
Amy WahlquistDepartment of Public Health Sciences, Medical University of South Carolina (MUSC), Charleston, SC.
Elizabeth Garrett-MayerDepartment of Public Health Sciences, Medical University of South Carolina (MUSC), Charleston, SC.
Kevin M GrayDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina (MUSC), Charleston, SC.
Anthony J AlbergDepartment of Public Health Sciences, Medical University of South Carolina (MUSC), Charleston, SC.
K Michael CummingsMedical University of South Carolina (MUSC), Hollings Cancer Center, Charleston, SC.
Matthew J CarpenterMedical University of South Carolina (MUSC), Hollings Cancer Center, Charleston, SC.
Medical University of South Carolina · USMUSC Hollings Cancer Center · USUniversity of Kentucky · USUniversity of Minnesota · US

Funding

Training in PharmacoNeuroImmune Substance Abuse ResearchT32DA007097 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MOLITOR, THOMAS WILLIAM · 1985 to 2021
$13.1M
The Dynamics of Smoking Cessation After Cancer Diagnosis: A Naturalisitic StudyK07CA181351 · NCI · UNIVERSITY OF KENTUCKY · PI BURRIS, JESSICA LYNN · 2014 to 2018
$769k
NCI NIH HHS K07 CA181351NCI NIH HHS L30 CA209711NIDA NIH HHS T32 DA007097
6 · The paper itself

Abstract

introductionSnus uptake is nominal among US smokers. This longitudinal study examines (1) perceptions of snus among US smokers given free snus for 6 weeks and (2) a method for assessment of an alternative tobacco product at the population level.

methodsAdult smokers (n = 543; 69.2% female; Mage = 49.3 years), uninterested in quitting, received free snus for ad libitum use. Based on their snus use during a 6-week sampling period, participants included: (1) never users (18.4%, n = 100); (2) experimenters; that is, used ≥ once, but not during the last week of sampling (33.1%; n = 180); and (3) persistent users; that is, used ≥ once during the final week, and ≥ once during any other week of the sampling period. (48.4%; n = 263).

resultsFollowing the sampling period, those who became persistent users were more likely than experimenters to report that switching to alternative tobacco products would lower their risk for health problems (66.5% vs. 50.0%; p = .006). Persistent users also reported greater negative affect relief and craving reduction (ps < .001) than experimenters. Finally, persistent users were more likely than experimenters to describe snus in favorable terms with respect to ease of use, satisfaction, and liking (ps < .05).

conclusionsSubjective experiences with snus, rather than nicotine dependence, explained experimentation versus persistent use. Even among smokers who became persistent snus users, snus was perceived as a poor substitute for cigarettes. This study design (randomized, yet naturalistic) could be extended to other novel tobacco products, including e-cigarettes, to help understand the role new products may have in the tobacco landscape. IMPLICATIONS: This is the first large scale, US-based naturalistic assessment of smokers' reactions to snus during an extended sampling period. This study is directly in line with FDA goals to better understand predictors of initiation, uptake, and use of other tobacco products such as snus, and serves as model for assessment methods of alternative tobacco products at the population level. Most smokers tried the provided sample of snus (approximately 82%). Subjective experiences with snus, rather than nicotine dependence, explained experimentation versus persistent use. Even among smokers who became persistent snus users, snus was perceived as a poor substitute for cigarettes.

Indexed as

PerceptionAdultCravingFemaleHumansLongitudinal StudiesMaleMiddle AgedSmokersSmokingTobacco, SmokelessTobacco Use Disorder

Identifiers

PMID28034999
PMCPMC5896465
OpenAlexW2566379664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.